Kirin Holdings Co. (OTCMKTS:KNBWY – Get Free Report) shares gapped up before the market opened on Friday. The stock had previously closed at $18.71, but opened at $19.5935. Kirin shares last traded at $19.6950, with a volume of 1,702 shares changing hands.
Analysts Set New Price Targets
Separately, Zacks Research raised shares of Kirin from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 29th. One research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, Kirin currently has an average rating of “Hold”.
View Our Latest Analysis on KNBWY
Kirin Price Performance
The company has a current ratio of 1.48, a quick ratio of 1.02 and a debt-to-equity ratio of 0.48. The business’s 50 day moving average price is $18.40 and its two-hundred day moving average price is $17.39. The stock has a market cap of $15.99 billion, a P/E ratio of 13.07 and a beta of 0.05.
Kirin (OTCMKTS:KNBWY – Get Free Report) last released its quarterly earnings results on Wednesday, November 11th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.09. Kirin had a net margin of 7.58% and a return on equity of 11.54%. The company had revenue of $3.99 billion during the quarter, compared to the consensus estimate of $4.04 billion. As a group, sell-side analysts expect that Kirin Holdings Co. will post 1.32 earnings per share for the current fiscal year.
About Kirin
Kirin Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets. The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.
Featured Stories
- Five stocks we like better than Kirin
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
- Firefly Aerospace Lights Up a High-Risk Space Opportunity
- Is Buying the NVIDIA Dip a Mistake? 3 Value Stocks Offer a Different Path Forward
Receive News & Ratings for Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
